Close Menu
    What's Hot

    ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

    July 27, 2026

    Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 27, 2026

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Generative AI Set to Transform Life Insurance Industry

    Life Insurance September 14, 2023By Greg Winterton
    Share
    Twitter LinkedIn Email

    Life insurance companies have a reputation for being something akin to an oil tanker – big, and slow. But their approach to incorporating generative AI (GenAI) into various functions of their businesses can hardly be claimed to be thus.

    A snap poll conducted by technology research and consulting firm, Celent, in June this year revealed that nearly 10% of life insurers in the United States were already using GenAI in production. And 50% said that they would be either using GenAI in a live environment or in a test environment before the year is out.

    The technology is being used mainly in customer experience, sales and marketing functions, for a few reasons. Chatbots, for example, are arguably already embedded in these front office functions in many industries, not only insurance, so it’s not unusual for consumers to interact with GenAI through this medium.

    But the tech is being used less so in middle and back-office functions, such as underwriting. According to Keith Raymond, Principal Analyst, Insurance at Celent, that’s because of the uncertainty around legal risk.

    “Underwriting is a risk area for insurance companies when using AI,” he said. “Large language models are trained with data that can be biased. Biases in underwriting rules are a key point for mitigation, all humans are biased, consciously or not.”

    The pace of change in the AI space has always been significant, but the release of GenAI provider ChatGPT in late November 2022 arguably thrust the technology into the public consciousness almost overnight.

    Government responses vary widely across the globe although most are looking for interoperability they have differing opinions on how to balance risk verse innovation. In the United States, the Biden-Harris administration convened leaders of seven major AI providers in July to secure voluntary commitments from them around safety and transparency, and Vice President Harris convened civil rights leaders earlier in July to discuss risks posed by the technology in terms of discrimination.

    These meetings were not insurance specific. But life insurers in the United States do have a yardstick by which to measure compliance when it comes to their use of AI. Back in 2020, the National Association of Insurance Commissioners (NAIC) published a document setting out principles which insurance companies should consider as they look to incorporate the technology into their businesses. But more recently, in July 2023, the NAIC published a Model Bulletin which specifically focuses on the use of large language models.

    “The NAIC model bulletin is a big leap forward in terms of structure and guidelines for life insurers and their use of AI,” said Raymond.

    These guidelines have been helpful, but best practice isn’t the law. And if Celent’s snap poll results turn out to be true – that half of all life insurers will have GenAI either working in a live environment at year end – then the customer experience, sales and marketing functions will still be the areas that see most of the investment, not just because of the efficiency gains this technology provides, but because of the lower regulatory risk.

    And the middle and back office is arguably where the most gains are to be made from incorporating GenAI into a life insurer’s technology stack. While the front-end use might help a life insurer to shift a few more policies or save money on headcount due to the ability of the GenAI system to do a good enough job to replace a sales representative, the significant benefit lies with the underwriting function, and the ability for GenAI to mitigate mortality risk.

    “Mortality risk is obviously a significant risk that life insurers are exposed to,” said Raymond. “Using GenAI in the underwriting process means that insurers will be able to manage mortality risk more effectively because they’ll be able to price policies more accurately. It’s an area of significant impact for an insurer.”

    The full potential of GenAI is unknown, but what is known is that this is more a freight train than an oil tanker, hurtling onwards at high speed.

    “The previous decade in the insurance technology space was all about the cloud – basically, migrating systems for efficiency reasons,” said Raymond. “But the next decade will be all about AI. For life insurance companies and regulators, this is a seismic change and it’s not slowing down. It could, in some ways, end up being the ‘forever decade’ for life insurers because of the enormity of the opportunity and the impact of it on not only the life insurance industry, but other industries that depend on it.”

    2023 - September Life Insurance Insurtech Longevity Risk Mortality Risk Volume 2 Issue 9 - September 2023
    Share. Twitter LinkedIn Email

    Related Posts

    ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

    July 27, 2026By LMI Newsdesk

    Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 27, 2026By LMI Newsdesk

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026By LMI Newsdesk

    Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 23, 2026By LMI Newsdesk
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.